BCAX Operating Cash Flow (Statement)
Bicara Therapeutics Inc · Operating Cash Flow (Statement)
BCAX Operating Cash Flow (Statement)
Latest reported-$134.85Mperiod ending
BCAX Cash from Operations (-$32.08M → -$134.85M)
Annual operating cash flow (statement)
High-resolution chart · PNG
BCAX operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -106,834,000 | |
| -74,751,000 | |
| -45,628,000 | |
| -32,076,000 |